RE: RE: From CompanyThe IND application he referred to is the Investigational New Drug Submission required to commence human clinical trials. This is where Pharmagap would present animal pharma and tox data, manufacturing/composition info and the proposed clinical trial protocols to the FDA or most likely to FDA/Health Canada and another regulatory body at the same time. It is a big undertaking but the necessary first step to conduct human trials .. there a few different types of IND's - I would be interested in knowing which route they are going to take.